~0 spots leftby Aug 2026

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

Recruiting in Palo Alto (17 mi)
Overseen ByVarun Monga, MD
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Varun Monga, MD
No Placebo Group
Breakthrough Therapy

Trial Summary

What is the purpose of this trial?This trial tests a new device that creates magnetic and electric fields, used while patients sleep. It targets adults whose brain cancer has returned after initial treatment. The device is combined with standard chemotherapy to see if it helps fight the cancer more effectively. The approach aims to suppress the growth of cancer cells.

Eligibility Criteria

Participant Groups

2Treatment groups
Experimental Treatment
Group I: Patients: sBE device applied during sleep, in combination with Lomustine and BevacizumabExperimental Treatment3 Interventions
The sBE device is to be used 8 hours a day by the patients, during sleep, for 8 weeks, while also receiving standard chemotherapy Lomustine and Bevacizumab
Group II: Partners of Patients (who sleep in same bed): sBEExperimental Treatment1 Intervention
Up to 12 associated unaffected partners may agree to sleep within the investigational sBE device congruent with the period of exposure of their rGBM partner (8 weeks + possible extension)

Find A Clinic Near You

Research locations nearbySelect from list below to view details:
University of Iowa Hospitals & ClinicsIowa City, IA
Loading ...

Who is running the clinical trial?

Varun Monga, MDLead Sponsor
University of IowaCollaborator

References